This information was published on 2023-09-21T10:53:45 for IP Right Registration Published.
Field | Value |
(210) | 2193580 |
(220) |
12 Jul 2021
|
(300) |
US, 11 Jan 2021, 90459478
|
(511) (510) |
Class 44
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services |
(540) |
|
(550) | Figurative |
(730) |
Adaptive Biotechnologies Corporation
|
(750) |
AJ Park
|
Find out more about publications on the About page.